RMI 9563

Known as: 3,9-fluoranthenedicarboxylic acid, bis(3-(diethylamino)propyl) ester, RMI 9563DA, RMI-9563 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1982
1982
RMI 9563DA inhibited the classical complement pathway in rat serum in vitro with an 150 of 51 micrograms/ml in diluted serum and… (More)
Is this relevant?
1978
1978
The immunopharmacology of RMI 9563 — bis[3-(diethylamino)propyl]fluoranthene-3,9-dicarboxylate dihydrochloride — has been… (More)
  • table 1
  • table 2
  • table 4
  • table 8
  • table 9
Is this relevant?